BRIEF published on 11/20/2025 at 07:05, 9 months 21 days ago SBO affiche une performance résiliente malgré les défis du marché Performance Financière Défis Du Marché Stratégie De Diversification Secteur De L'énergie Progrès Technologiques
BRIEF published on 11/20/2025 at 07:05, 9 months 21 days ago NFON AG Reports Stable Q3 Results Amid Challenging Market Revenue Growth AI Solutions NFON AG Adjusted Guidance Q3 2025 Results
BRIEF published on 11/20/2025 at 07:05, 9 months 21 days ago NFON AG annonce des résultats stables au troisième trimestre malgré un marché difficile NFON AG Croissance Des Revenus Solutions D'IA Résultats Du Troisième Trimestre 2025 Recommandations Ajustées
BRIEF published on 11/20/2025 at 07:05, 9 months 21 days ago Swaine Honored with Prestigious Walpole Award in UK Expansion Internationale Chargeurs Invest Swaine Luxe Britannique Walpole Award
BRIEF published on 11/20/2025 at 07:05, 9 months 21 days ago Swaine Honored with Walpole Award for Craftsmanship in UK Chargeurs Invest Swaine Walpole Award Luxury Craftsmanship Luxury Industry
BRIEF published on 11/20/2025 at 06:35, 9 months 21 days ago Avolta Secures Two 10-Year Contracts at Washington Dulles Digital Engagement Avolta Retail Expansion Local Brands Washington Dulles
BRIEF published on 11/20/2025 at 06:35, 9 months 21 days ago Avolta décroche deux contrats de 10 ans à Washington Dulles Engagement Numérique Expansion Du Commerce De Détail Marques Locales Washington Dulles Volta
BRIEF published on 11/20/2025 at 06:35, 9 months 21 days ago Ranibizumab Biosimilar Epruvy® Launched in Germany Formycon AG Ranibizumab Biosimilar Germany Launch Ophthalmic Care
BRIEF published on 11/20/2025 at 06:35, 9 months 21 days ago Lancement en Allemagne du biosimilaire de ranibizumab Epruvy® Formycon AG Ranibizumab Biosimilaire Lancement En Allemagne Soins Ophtalmiques
BRIEF published on 11/20/2025 at 06:07, 9 months 21 days ago Eurotunnel Disputes Proposed Business Rates Hike in Great Britain Eurotunnel Great Britain Business Rates Valuation Office Agency Franco-British Concession
Published on 09/11/2026 at 04:00, 8 hours 28 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 14 hours 3 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 21 hours 8 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 28 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 45 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 52 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 58 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 13 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 28 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 28 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 28 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 58 minutes ago Availability of the 2026 Interim Financial Report
